Current Genscript Biotech forecasts and price targets in November 2026
Ø Analyst Price Targets
2.67 USD
-30.60 %
Median
2.53 USD
-34.38 %
Max
30.19 USD
Min
16.06 USD
Last Price
3.85 USD
Buy
15
Hold
1
Sell
0
The average target price for Genscript Biotech is 2.67 USD. (-30.60 % below the current price)
The median price target of Genscript Biotech is 2.53 USD.
Stock analysts from many renowned investment banks are closely examining the Genscript Biotech stock. They conclude their professional Genscript Biotech stock analyses with a clear recommendation for the Genscript Biotech stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-04-01 | 15 | 1 | 0 | — |
| 2026-03-01 | 15 | 1 | 0 | 2.67 USD |
| 2026-02-01 | 15 | 1 | 0 | 2.93 USD |
| 2026-01-01 | 15 | 1 | 0 | 3.11 USD |
| 2025-12-01 | 14 | 1 | 0 | 3.15 USD |
| 2025-11-01 | 14 | 1 | 0 | 3.15 USD |
Genscript Biotech Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Genscript Biotech in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 893.00 M USD | 28.00 M USD | 0.01 USD |
| 2027e | 1.18 B USD | 199.00 M USD | 0.09 USD |
| 2028e | 1.49 B USD | 350.00 M USD | 0.16 USD |